Virus Diseases Completed Phase 2 Trials for Danirixin (DB11922)

Also known as: Virus Disease

IndicationStatusPhase
DBCOND0028162 (Virus Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02469298Safety, Tolerability and Clinical Effect of Danirixin in Adults With InfluenzaTreatment